Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Your view on KBYPF
Overview
What the company does, where it operates, and who runs it.
About Kobayashi Pharmaceutical Co., Ltd.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Yumi Nakagawa
- Headquarters
- KDX Kobayashi Doshomachi Building, Osaka, JP
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Yumi Nakagawa
- Headquarters
- KDX Kobayashi Doshomachi Building, Osaka, JP
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers.
It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products.
Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods.
Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Kobayashi Pharmaceutical Co., Ltd., and the rating behind it. KBYPF last traded at $34.05, 263.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Kobayashi Pharmaceutical Co., Ltd.. Starting points for Kobayashi Pharmaceutical Co., Ltd.: P/E 263.7, EPS $21.87, beta 0.27 — an Household & Personal Products name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Kobayashi Pharmaceutical Co., Ltd.. Kobayashi Pharmaceutical Co., Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Kobayashi Pharmaceutical Co., Ltd.. Trailing twelve-month EPS for Kobayashi Pharmaceutical Co., Ltd. stands at $21.87. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Kobayashi Pharmaceutical Co., Ltd.. Kobayashi Pharmaceutical Co., Ltd. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Kobayashi Pharmaceutical Co., Ltd. valued side by side against its closest peers. Kobayashi Pharmaceutical Co., Ltd. is measured against Household & Personal Products peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Kobayashi Pharmaceutical Co., Ltd., and how their positions are changing. At a $2.53B market value, institutional positions materially move Kobayashi Pharmaceutical Co., Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Kobayashi Pharmaceutical Co., Ltd. executives and directors. Shares of Kobayashi Pharmaceutical Co., Ltd. have traded between $34.05 and $37.43 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Kobayashi Pharmaceutical Co., Ltd.. Kobayashi Pharmaceutical Co., Ltd. is a $2.53B Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Kobayashi Pharmaceutical Co., Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Kobayashi Pharmaceutical Co., Ltd.. Coverage tracks Kobayashi Pharmaceutical Co., Ltd. within Household & Personal Products (Consumer Defensive). Press releases and market coverage, newest first.